Navigation Links
Access MediQuip Names Prakash Patel Chief Executive Officer
Date:2/1/2011

LAKE MARY, Fla., Feb. 1, 2011 /PRNewswire/ -- Access MediQuip (AMQ), the nation's first and largest provider of surgical implant management solutions, announced the appointment of Prakash Patel, M.D. to chief executive officer. He currently serves as the company's chief operating and chief clinical officer, and brings over 14 years of health care experience to the CEO position, including operations, product development, network, alliances, acquisitions and strategy. As part of a planned transition, Patel replaces outgoing CEO Tim Hargarten who will continue to provide his strategic insight and expertise as a member of AMQ's Board of Directors.

(Logo: http://photos.prnewswire.com/prnh/20090310/CG80801LOGO)

"On behalf of Access MediQuip's Board of Directors, I am very pleased that Dr. Patel will be leading the company going forward," said Steve Cosler, chairman of the board of AMQ. "He will continue to build on the progress the company has made under Tim Hargarten's leadership, positioning the company for continued growth and leadership in this important and emerging specialty health sector of surgical implant management."

Since he joined AMQ in November 2010, Patel has been leading the company's cost of care initiatives, which include manufacturer contracting, network development and management, site of care optimization, and clinical utilization management. He was also leading all provider and facility initiatives as well as device sourcing and clinical programs focused on the delivery of cost savings for payers and employers and improved clinical outcomes for patients.

"AMQ is a company that is in the right place at the right time," Patel said. "I look forward to building upon the strong foundation that Tim Hargarten and everyone at AMQ has created over the years. We will focus on speed-to-market strategies for the surgical implant sector to reduce rapidly increasing costs while helping to improve quality care. That's the market opportunity of the future, and for AMQ it's a bright one."

Patel joined AMQ from Magellan Health Services, where he served on the executive leadership team as Chief Corporate Development Officer, responsible for mergers and acquisitions and other strategic business initiatives. He also led operations at Magellan's National Imaging Associates (NIA) where he built out network capabilities, addressed cost-of care issues and supported product development. Prior to Magellan, Patel held positions as chief executive officer of Imericius Healthcare, managing director of Internet Healthcare Group, and served as a vice president of Scheer and Company.

About Access MediQuip

Access MediQuip created the first surgical implant management solution more than 12 years ago, has dedicated, skilled personnel focused exclusively on surgical implant management solutions and operates the largest surgical implant network in the nation. The company is headquartered in Lake Mary, Florida, and has an operations facility in Houston, Texas.


'/>"/>
SOURCE Access MediQuip
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
2. Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
3. Hypertension: Journal of the American Heart Association Rapid Access Reports: Hispanics Hypertension Better Controlled With Equal Access to Care
4. Anesiva Announces Pivotal Phase 3 Trial of Zingo(TM) Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults
5. Access Pharmaceuticals to Present Data on ProLindac(TM) at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
6. Access Pharmaceuticals Announces Two Poster Presentations Reporting Significant Preclinical Data on ProLindac(TM) at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
7. Demand for Spanish-Language Cancer Web Materials Quadruples; Internet Resources and Access Remain Scarce
8. New Analysis from 14 Countries Identifies Drug Access Priorities to Achieve 2010 AIDS Treatment Target
9. Access Pharmaceuticals Demonstrates Ability to Significantly Reduce Glucose Levels in Pre-clinical Testing of Cobalamin(TM) Oral Insulin
10. Childrens Hospital Cancer Study Finds Adolescents and Young Adults Dont Get Same Access to Cutting-Edge Treatment as Younger Patients
11. Insmed Provides Update on IPLEX(TM) Expanded Access Program in Italy for the Treatment of Amyotrophic Lateral Sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... , Oct. 10, 2017  NDS received FDA 510(k) clearance ... a medical-grade battery-powered display stand specifically designed for endoscopy environments. An ... technology into a clinical solution to support the improvement of patient ... Innovative Design ... Wireless Solution ...
(Date:10/5/2017)... Ill. , Oct. 5, 2017  In ... Association of Oral and Maxillofacial Surgeons (AAOMS) released ... opioids – to be used as a first-line ... pain. Recognizing ... the AAOMS White Paper "Opioid Prescribing: Acute and ...
(Date:10/4/2017)... Oct. 4, 2017 OBP Medical ... illuminating medical devices, today announced regulatory approval from ... Agency (or Agência Nacional de Vigilância Sanitária (ANVISA)) ... cordless surgical retractor with integrated LED light source ... illumination and exposure of a tissue pocket or ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian ... On The Brink” is the creation of published author, William Nowers. Captain Nowers ... a WWII veteran, he spent thirty years in the Navy. Following his career ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company ... of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every ... meet the highest standard. , These products are also: Gluten Free, Non-GMO, ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... system that we intend to develop to enable prevention of a major side ... severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... On Saturday, ... a treadmill relay – Miles by Moonlight to raise money for the American Heart ... or more. , Teams will work together to keep their treadmills moving for ...
(Date:10/12/2017)... ... 2017 , ... Vohra Chief Medical Officer Dr. Shark Bird, ... nursing facility medical directors and other clinicians at various events in October. His ... many of these conferences we get to educate other physicians, facility nurses, corporate ...
Breaking Medicine News(10 mins):